Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Pediatric study characterizes recurrent PSC

Key clinical point: Children who have recurrence of primary sclerosing cholangitis after liver transplant tend to be younger and have more rapidly progressive disease.

Major finding: Recurrence was significantly associated with younger median age at time of transplant (13.2 vs. 16.2 years).

Study details: A retrospective study involving 149 children who underwent liver transplant for primary sclerosing cholangitis.

Disclosures: The investigators disclosed relationships with Gilead, Merck, Novartis, and others.

Citation:

Martinez M et al. The Liver Meeting 2019, Abstract 44.